Alzchem Group Reports Nine-Month Revenue, EBITDA Growth and Confirms Guidance
Revenue rose 4% and EBITDA increased 8% in the first nine months of 2026. Net profit was higher than in the prior-year period. Alzchem confirmed its full-year revenue and EBITDA guidance. In the third quarter, revenue grew slightly, while EBITDA declined due to higher energy and raw material costs and startup expenses for new production capacities.
Alzchem Group AG reported a 4% increase in revenue to 443.8 million Euro and an 8% rise in EBITDA to 93.2 million Euro for the first nine months of 2026. Net profit for the period reached 48.4 million Euro, compared to 46.8 million Euro in the prior-year period. In the third quarter, revenue grew slightly to nearly 140 million Euro, though EBITDA declined to 28.7 million Euro from 29.7 million Euro due to higher energy and raw material costs as well as startup expenses for new production capacities. The company confirmed its full-year guidance, targeting 600 million Euro in revenue and approximately 126 million Euro in EBITDA.